日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Halorhodospira halophila Peptide chain release factor 3 (prfC), partial CSB-YP381019HSG
CSB-EP381019HSG
CSB-BP381019HSG
CSB-MP381019HSG
CSB-EP381019HSG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Halorhodospira halophila Cysteine--tRNA ligase (cysS) CSB-YP381020HSG
CSB-EP381020HSG
CSB-BP381020HSG
CSB-MP381020HSG
CSB-EP381020HSG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Halorhodospira halophila Dihydroorotate dehydrogenase (quinone) CSB-YP381021HSG
CSB-EP381021HSG
CSB-BP381021HSG
CSB-MP381021HSG
CSB-EP381021HSG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Halorhodospira halophila Recombination protein RecR (recR) CSB-YP381022HSG
CSB-EP381022HSG
CSB-BP381022HSG
CSB-MP381022HSG
CSB-EP381022HSG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Halorhodospira halophila 50S ribosomal protein L20 (rplT) CSB-YP381023HSG
CSB-EP381023HSG
CSB-BP381023HSG
CSB-MP381023HSG
CSB-EP381023HSG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Halorhodospira halophila tRNA (guanine-N (1)-)-methyltransferase CSB-YP381024HSG
CSB-EP381024HSG
CSB-BP381024HSG
CSB-MP381024HSG
CSB-EP381024HSG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Halorhodospira halophila 3-phosphoshikimate 1-carboxyvinyltransferase (aroA) CSB-YP381025HSG
CSB-EP381025HSG
CSB-BP381025HSG
CSB-MP381025HSG
CSB-EP381025HSG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Halorhodospira halophila Trigger factor (tig) CSB-YP381026HSG
CSB-EP381026HSG
CSB-BP381026HSG
CSB-MP381026HSG
CSB-EP381026HSG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Halorhodospira halophila Flavoprotein wrbA (wrbA) CSB-YP381027HSG
CSB-EP381027HSG
CSB-BP381027HSG
CSB-MP381027HSG
CSB-EP381027HSG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Halorhodospira halophila 30S ribosomal protein S18 (rpsR) CSB-YP381028HSG
CSB-EP381028HSG
CSB-BP381028HSG
CSB-MP381028HSG
CSB-EP381028HSG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Halorhodospira halophila 30S ribosomal protein S6 (rpsF) CSB-YP381029HSG
CSB-EP381029HSG
CSB-BP381029HSG
CSB-MP381029HSG
CSB-EP381029HSG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Halorhodospira halophila Pantothenate synthetase (panC) CSB-YP381030HSG
CSB-EP381030HSG
CSB-BP381030HSG
CSB-MP381030HSG
CSB-EP381030HSG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Halorhodospira halophila Proline--tRNA ligase (proS), partial CSB-YP381031HSG
CSB-EP381031HSG
CSB-BP381031HSG
CSB-MP381031HSG
CSB-EP381031HSG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Halorhodospira halophila Undecaprenyl-diphosphatase (uppP), partial CSB-YP381032HSG
CSB-EP381032HSG
CSB-BP381032HSG
CSB-MP381032HSG
CSB-EP381032HSG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Halorhodospira halophila Dihydroorotase (pyrC) CSB-YP381033HSG
CSB-EP381033HSG
CSB-BP381033HSG
CSB-MP381033HSG
CSB-EP381033HSG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Halorhodospira halophila DNA-directed RNA polymerase subunit alpha (rpoA) CSB-YP381034HSG
CSB-EP381034HSG
CSB-BP381034HSG
CSB-MP381034HSG
CSB-EP381034HSG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Halorhodospira halophila 30S ribosomal protein S13 (rpsM) CSB-YP381035HSG
CSB-EP381035HSG
CSB-BP381035HSG
CSB-MP381035HSG
CSB-EP381035HSG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Halorhodospira halophila 30S ribosomal protein S5 (rpsE) CSB-YP381036HSG
CSB-EP381036HSG
CSB-BP381036HSG
CSB-MP381036HSG
CSB-EP381036HSG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Halorhodospira halophila 50S ribosomal protein L18 (rplR) CSB-YP381037HSG
CSB-EP381037HSG
CSB-BP381037HSG
CSB-MP381037HSG
CSB-EP381037HSG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Halorhodospira halophila 50S ribosomal protein L5 (rplE) CSB-YP381038HSG
CSB-EP381038HSG
CSB-BP381038HSG
CSB-MP381038HSG
CSB-EP381038HSG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×